Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$439.79
+0.47%
Mkt Cap $10.47B
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (39 analysts)
$677.00
Range $542.00 – $962.00
Implied Upside
+53.9%
Consensus $677.00 vs current $439.79